Alignment Healthcare, Inc.

NASDAQ:ALHC

15.42 (USD) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 926.932701.241692.433681.286628.601465.387456.709462.379439.155361.811360.348366.474345.526298.274293.466308.951267.082242.409247.867244.313224.633
Cost of Revenue 820.9614.896613.444605.312573.218417.762397.879410.644396.315326.002312.85307.269303.758259.571253.99274.385251.095215.014190.08194.502193.396
Gross Profit 106.03286.34578.98975.97455.38347.62558.8351.73542.8435.80947.49859.20541.76838.70339.47634.56615.98727.39557.78749.81131.237
Gross Profit Ratio 0.1140.1230.1140.1120.0880.1020.1290.1120.0980.0990.1320.1620.1210.130.1350.1120.060.1130.2330.2040.139
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 0000076.78100075.2700074.500049.614000
Selling & Marketing Expenses 000006.9560007.9580003.5810001.505000
SG&A 103.831102.12890.87187.86390.51283.73783.08970.19970.40883.22876.45261.67374.29378.08176.84671.1564.91451.11938.79433.69832.787
Other Expenses 007.64-94.356-96.4890.1420.1450.4284.9214.6874.4564.183.950.0840.0480.0590.0380.0380.057-0.03-0.797
Operating Expenses 111.425108.8998.51194.35696.48989.53888.58675.39475.32987.91580.90865.85378.24382.16980.92675.05868.65155.1942.72737.22436.352
Operating Income -5.393-22.545-19.522-18.382-41.106-41.913-29.756-23.659-32.489-52.106-33.41-6.648-36.475-43.466-41.45-40.492-52.664-27.79515.0612.587-5.115
Operating Income Ratio -0.006-0.032-0.028-0.027-0.065-0.09-0.065-0.051-0.074-0.144-0.093-0.018-0.106-0.146-0.141-0.131-0.197-0.1150.0610.052-0.023
Total Other Income Expenses Net -3.94-8.512-6.915-5.599-5.469-5.342-5.321-4.834-4.881-4.717-6.67-4.932-4.342-4.368-4.366-4.27-4.21-3.371-4.214-4.222-4.957
Income Before Tax -9.333-31.057-26.437-23.981-46.575-47.255-35.077-28.493-37.37-56.823-40.08-11.58-40.817-47.834-45.816-44.762-56.874-32.06510.8468.365-10.072
Income Before Tax Ratio -0.01-0.044-0.038-0.035-0.074-0.102-0.077-0.062-0.085-0.157-0.111-0.032-0.118-0.16-0.156-0.145-0.213-0.1320.0440.034-0.045
Income Tax Expense 0.0210.007-0.0080.022-0.054-0.024-0.030.0010.0010.1720.1674.9324.3424.5364.4624.3884.2864.3464.3284.1623.363
Net Income -9.114-31.091-26.413-24.01-46.521-47.209-35.047-28.477-37.371-56.995-40.247-16.512-45.159-47.834-45.816-44.762-56.874-32.06510.8468.365-10.072
Net Income Ratio -0.01-0.044-0.038-0.035-0.074-0.101-0.077-0.062-0.085-0.158-0.112-0.045-0.131-0.16-0.156-0.145-0.213-0.1320.0440.034-0.045
EPS -0.05-0.16-0.14-0.13-0.25-0.25-0.19-0.15-0.2-0.31-0.22-0.091-0.25-0.27-0.26-0.25-0.37-0.210.0710.055-0.066
EPS Diluted -0.05-0.16-0.14-0.13-0.25-0.25-0.19-0.15-0.2-0.31-0.22-0.091-0.25-0.27-0.26-0.25-0.37-0.210.0710.055-0.066
EBITDA 2.244-18.92-11.814-11.751-35.119-35.91-24.05-17.967-27.369-47.279-30.962-2.861-32.423-39.233-37.269-36.471-48.837-22.78719.13716.171-2.84
EBITDA Ratio 0.002-0.027-0.017-0.017-0.056-0.077-0.053-0.039-0.062-0.131-0.086-0.008-0.094-0.132-0.127-0.118-0.183-0.0940.0770.066-0.013